Sci - Spinal Cord Injury Clinical Trials
2 recruiting trials for Sci - Spinal Cord Injury. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Sci - Spinal Cord Injury clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Karunesh Ganguly (1), Seoul National University Hospital (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is PMT/Blackrock Combination Device (device, 1 trial), followed by Shoulder orthosis.
Track Sci - Spinal Cord Injury trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
ECoG BMI for Motor and Speech Control
Test the feasibility of using electrocorticography (ECoG) signals to control complex devices for motor and speech control in adults severely affected by neurological disorders.
The Effect of a Muscle-mimicking, Fabric-type Shoulder Orthosis on Functional Movements of the Upper Limb in Patients...
The goal of this clinical trial is to investigate the effect of a muscle-mimicking, fabric-type shoulder orthosis on functional movements of the upper limb in patients with...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Sci - Spinal Cord Injury, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Sci - Spinal Cord Injury, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Sci - Spinal Cord Injury, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.